| Primary |
| Product Used For Unknown Indication |
31.5% |
| Depression |
20.1% |
| Drug Use For Unknown Indication |
20.1% |
| Headache |
3.8% |
| Enuresis |
3.3% |
| Bipolar Disorder |
2.7% |
| Drug Abuse |
2.7% |
| Major Depression |
2.2% |
| Anxiety |
1.6% |
| Attention Deficit/hyperactivity Disorder |
1.6% |
| Overdose |
1.6% |
| Anaesthesia |
1.1% |
| Bipolar I Disorder |
1.1% |
| Cancer Pain |
1.1% |
| Dysthymic Disorder |
1.1% |
| Incontinence |
1.1% |
| Panic Disorder |
1.1% |
| Paranoia |
1.1% |
| Abnormal Behaviour |
0.5% |
| Agoraphobia |
0.5% |
|
| Completed Suicide |
28.6% |
| Death |
12.5% |
| Rash |
5.4% |
| Respiratory Arrest |
5.4% |
| Toxicity To Various Agents |
5.4% |
| Tremor |
5.4% |
| Intentional Drug Misuse |
3.6% |
| Oculogyric Crisis |
3.6% |
| Somnolence |
3.6% |
| Suicidal Ideation |
3.6% |
| Therapeutic Agent Toxicity |
3.6% |
| Urinary Retention |
3.6% |
| Vision Blurred |
3.6% |
| Accidental Overdose |
1.8% |
| Blood Magnesium Decreased |
1.8% |
| Constipation |
1.8% |
| Death Of Relative |
1.8% |
| Dizziness |
1.8% |
| Drug Abuse |
1.8% |
| Dystonia |
1.8% |
|
| Secondary |
| Product Used For Unknown Indication |
31.0% |
| Drug Abuse |
17.8% |
| Drug Use For Unknown Indication |
15.2% |
| Depression |
7.0% |
| Drug Exposure During Pregnancy |
5.5% |
| Hypertension |
3.4% |
| Laxative Supportive Care |
2.7% |
| Mental Disorder |
2.2% |
| Pain |
2.1% |
| Anxiety |
1.7% |
| Agoraphobia |
1.5% |
| Dermatitis Diaper |
1.4% |
| Headache |
1.3% |
| Sedative Therapy |
1.3% |
| Bipolar Disorder |
1.1% |
| Suicide Attempt |
1.0% |
| Antipsychotic Drug Level Therapeutic |
0.9% |
| Ill-defined Disorder |
0.9% |
| Off Label Use |
0.9% |
| Adverse Drug Reaction |
0.9% |
|
| Completed Suicide |
21.7% |
| Drug Exposure During Pregnancy |
9.0% |
| Toxicity To Various Agents |
8.4% |
| Sudden Death |
7.2% |
| Drug Toxicity |
6.0% |
| Respiratory Arrest |
5.4% |
| Unresponsive To Stimuli |
4.2% |
| Urinary Retention |
4.2% |
| Cardio-respiratory Arrest |
3.6% |
| Death |
3.6% |
| Palpitations |
3.6% |
| Somnolence |
3.6% |
| Suicide Attempt |
3.6% |
| Poisoning |
3.0% |
| Angle Closure Glaucoma |
2.4% |
| Tachycardia |
2.4% |
| Vision Blurred |
2.4% |
| Drug Abuse |
1.8% |
| Maternal Drugs Affecting Foetus |
1.8% |
| Pupillary Light Reflex Tests Abnormal |
1.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Depression |
15.6% |
| Drug Use For Unknown Indication |
10.6% |
| Anxiety |
8.6% |
| Pain |
5.1% |
| Hypertension |
4.6% |
| Rheumatoid Arthritis |
3.0% |
| Multiple Sclerosis |
3.0% |
| Bipolar Disorder |
2.6% |
| Hormone Replacement Therapy |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Neuralgia |
2.4% |
| Asthma |
2.1% |
| Osteoporosis |
2.0% |
| Insomnia |
1.9% |
| Breast Cancer |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Schizophrenia |
1.6% |
| Sleep Disorder |
1.6% |
| Smoking Cessation Therapy |
1.5% |
|
| Weight Increased |
11.9% |
| Vomiting |
11.7% |
| Weight Decreased |
11.4% |
| Type 2 Diabetes Mellitus |
7.5% |
| Pain In Extremity |
4.9% |
| Urinary Tract Infection |
4.9% |
| Pain |
4.4% |
| Withdrawal Syndrome |
4.4% |
| Pulmonary Embolism |
3.9% |
| Visual Acuity Reduced |
3.9% |
| Drug Ineffective |
3.6% |
| Vision Blurred |
3.6% |
| Headache |
3.4% |
| Nausea |
3.4% |
| Suicidal Ideation |
3.1% |
| Erectile Dysfunction |
2.8% |
| Syncope |
2.8% |
| Tremor |
2.8% |
| Wheezing |
2.8% |
| Somnolence |
2.6% |
|
| Interacting |
| Mental Disorder |
22.2% |
| Product Used For Unknown Indication |
12.5% |
| Convulsion |
8.3% |
| Depression |
8.3% |
| Dysthymic Disorder |
6.9% |
| Bipolar Disorder |
5.6% |
| Cellulitis |
5.6% |
| Major Depression |
5.6% |
| Drug Use For Unknown Indication |
4.2% |
| Aggression |
2.8% |
| Attention Deficit/hyperactivity Disorder |
2.8% |
| Depressed Mood |
2.8% |
| Headache |
2.8% |
| Pyelonephritis |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Dementia |
1.4% |
| Multiple Sclerosis |
1.4% |
| Osteoporosis |
1.4% |
|
| Oculogyric Crisis |
17.6% |
| Tremor |
17.6% |
| Galactorrhoea |
11.8% |
| Anxiety |
5.9% |
| Drug Interaction |
5.9% |
| Electrocardiogram Qt Prolonged |
5.9% |
| Fall |
5.9% |
| Muscle Twitching |
5.9% |
| Serotonin Syndrome |
5.9% |
| Skin Hypertrophy |
5.9% |
| Syncope |
5.9% |
| Weight Decreased |
5.9% |
|
